{"entity":{"type":"insider","cik":"0001775490","url":"/insider/0001775490","json_url":"/insider/0001775490.json","name":"Shendelman Shoshana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":14,"first":"2019-05-20","last":"2024-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Shendelman Shoshana","source":"filing","n_filings":14,"first_seen":"2019-05-20","last_seen":"2024-08-14"}],"transactions":[{"id":2985960,"accession":"0000950170-24-097309","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-097309","line_url":"/filing/0000950170-24-097309#line-5","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119591.0,"shares_display":"119,591","price_per_share":5.93,"price_display":"5.93","price_state":"stated","total_value":709174.63,"total_display":"709,174.63","total_whole":"709,175","shares_owned_after":4690839.0,"shares_owned_after_display":"4,690,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider"},{"id":2985953,"accession":"0000950170-24-097309","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-097309","line_url":"/filing/0000950170-24-097309#line-4","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357423.0,"shares_display":"357,423","price_per_share":6.18,"price_display":"6.18","price_state":"stated","total_value":2208874.14,"total_display":"2,208,874.14","total_whole":"2,208,874","shares_owned_after":4810430.0,"shares_owned_after_display":"4,810,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-14","scope":"insider"},{"id":2985948,"accession":"0000950170-24-097309","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-097309","line_url":"/filing/0000950170-24-097309#line-3","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":1794000.0,"total_display":"1,794,000.00","total_whole":"1,794,000","shares_owned_after":5167853.0,"shares_owned_after_display":"5,167,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":2677681,"accession":"0000950170-24-071333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-071333","line_url":"/filing/0000950170-24-071333#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61795.0,"shares_display":"61,795","price_per_share":4.32,"price_display":"4.32","price_state":"stated","total_value":266954.4,"total_display":"266,954.40","total_whole":"266,954","shares_owned_after":3756019.0,"shares_owned_after_display":"3,756,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2024-06-10","scope":"insider"},{"id":2397975,"accession":"0001096906-24-000497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001096906-24-000497","line_url":"/filing/0001096906-24-000497#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318573.0,"shares_display":"318,573","price_per_share":5.39,"price_display":"5.39","price_state":"stated","total_value":1717108.47,"total_display":"1,717,108.47","total_whole":"1,717,108","shares_owned_after":3817814.0,"shares_owned_after_display":"3,817,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider"},{"id":8441664,"accession":"0001209191-23-057117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057117","line_url":"/filing/0001209191-23-057117#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3968.0,"shares_display":"3,968","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":7816.96,"total_display":"7,816.96","total_whole":"7,817","shares_owned_after":2596387.0,"shares_owned_after_display":"2,596,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":7816542,"accession":"0001209191-23-050892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050892","line_url":"/filing/0001209191-23-050892#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115632.0,"shares_display":"115,632","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":312206.4,"total_display":"312,206.40","total_whole":"312,206","shares_owned_after":2600355.0,"shares_owned_after_display":"2,600,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8627001,"accession":"0001209191-23-003290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003290","line_url":"/filing/0001209191-23-003290#line-2","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15870.0,"shares_display":"15,870","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":14441.7,"total_display":"14,441.70","total_whole":"14,442","shares_owned_after":751625.0,"shares_owned_after_display":"751,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider"},{"id":6987864,"accession":"0001209191-22-053691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053691","line_url":"/filing/0001209191-22-053691#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.645,"price_display":"0.64","price_state":"stated","total_value":32250.0,"total_display":"32,250.00","total_whole":"32,250","shares_owned_after":767495.0,"shares_owned_after_display":"767,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-14","scope":"insider"},{"id":6926629,"accession":"0001209191-22-053604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053604","line_url":"/filing/0001209191-22-053604#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73256.0,"shares_display":"73,256","price_per_share":0.5582,"price_display":"0.56","price_state":"stated","total_value":40891.4992,"total_display":"40,891.50","total_whole":"40,891","shares_owned_after":717495.0,"shares_owned_after_display":"717,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-13","scope":"insider"},{"id":6753940,"accession":"0001209191-22-053530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053530","line_url":"/filing/0001209191-22-053530#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38153.0,"shares_display":"38,153","price_per_share":0.5227,"price_display":"0.52","price_state":"stated","total_value":19942.5731,"total_display":"19,942.57","total_whole":"19,943","shares_owned_after":644239.0,"shares_owned_after_display":"644,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-12","scope":"insider"},{"id":4955915,"accession":"0001209191-21-055932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055932","line_url":"/filing/0001209191-21-055932#line-2","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9300.0,"shares_display":"9,300","price_per_share":14.4882,"price_display":"14.49","price_state":"stated","total_value":134740.26,"total_display":"134,740.26","total_whole":"134,740","shares_owned_after":364286.0,"shares_owned_after_display":"364,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider"},{"id":4955910,"accession":"0001209191-21-055932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055932","line_url":"/filing/0001209191-21-055932#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":701.0,"shares_display":"701","price_per_share":14.6899,"price_display":"14.69","price_state":"stated","total_value":10297.6199,"total_display":"10,297.62","total_whole":"10,298","shares_owned_after":354986.0,"shares_owned_after_display":"354,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider"},{"id":2338971,"accession":"0001209191-20-043427","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-11","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12051.0,"shares_display":"12,051","price_per_share":25.45,"price_display":"25.45","price_state":"stated","total_value":306697.95,"total_display":"306,697.95","total_whole":"306,698","shares_owned_after":557235.0,"shares_owned_after_display":"557,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-22","scope":"insider"},{"id":2338968,"accession":"0001209191-20-043427","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-10","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2949.0,"shares_display":"2,949","price_per_share":26.51,"price_display":"26.51","price_state":"stated","total_value":78177.99,"total_display":"78,177.99","total_whole":"78,178","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-22","scope":"insider"},{"id":2338961,"accession":"0001209191-20-043427","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-8","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7600.0,"shares_display":"7,600","price_per_share":26.69,"price_display":"26.69","price_state":"stated","total_value":202844.0,"total_display":"202,844.00","total_whole":"202,844","shares_owned_after":561685.0,"shares_owned_after_display":"561,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider"},{"id":2338958,"accession":"0001209191-20-043427","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-7","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":27.42,"price_display":"27.42","price_state":"stated","total_value":200166.0,"total_display":"200,166.00","total_whole":"200,166","shares_owned_after":554385.0,"shares_owned_after_display":"554,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider"},{"id":2338957,"accession":"0001209191-20-043427","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-6","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":28.24,"price_display":"28.24","price_state":"stated","total_value":2824.0,"total_display":"2,824.00","total_whole":"2,824","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider"},{"id":2338952,"accession":"0001209191-20-043427","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-4","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12100.0,"shares_display":"12,100","price_per_share":27.19,"price_display":"27.19","price_state":"stated","total_value":328999.0,"total_display":"328,999.00","total_whole":"328,999","shares_owned_after":557185.0,"shares_owned_after_display":"557,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":2338950,"accession":"0001209191-20-043427","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-3","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":27.88,"price_display":"27.88","price_state":"stated","total_value":72488.0,"total_display":"72,488.00","total_whole":"72,488","shares_owned_after":554585.0,"shares_owned_after_display":"554,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":2338947,"accession":"0001209191-20-043427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043427","line_url":"/filing/0001209191-20-043427#line-2","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":28.64,"price_display":"28.64","price_state":"stated","total_value":8592.0,"total_display":"8,592.00","total_whole":"8,592","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":2967338,"accession":"0001209191-20-042085","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-9","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10936.0,"shares_display":"10,936","price_per_share":30.9,"price_display":"30.90","price_state":"stated","total_value":337922.4,"total_display":"337,922.40","total_whole":"337,922","shares_owned_after":558349.0,"shares_owned_after_display":"558,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-09","scope":"insider"},{"id":2967333,"accession":"0001209191-20-042085","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-8","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4064.0,"shares_display":"4,064","price_per_share":31.64,"price_display":"31.64","price_state":"stated","total_value":128584.96,"total_display":"128,584.96","total_whole":"128,585","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-09","scope":"insider"},{"id":2967324,"accession":"0001209191-20-042085","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-6","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12889.0,"shares_display":"12,889","price_per_share":32.21,"price_display":"32.21","price_state":"stated","total_value":415154.69,"total_display":"415,154.69","total_whole":"415,155","shares_owned_after":556396.0,"shares_owned_after_display":"556,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-09","scope":"insider"},{"id":2967319,"accession":"0001209191-20-042085","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-5","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2111.0,"shares_display":"2,111","price_per_share":32.98,"price_display":"32.98","price_state":"stated","total_value":69620.78,"total_display":"69,620.78","total_whole":"69,621","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-09","scope":"insider"},{"id":2967306,"accession":"0001209191-20-042085","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-3","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13005.0,"shares_display":"13,005","price_per_share":32.25,"price_display":"32.25","price_state":"stated","total_value":419411.25,"total_display":"419,411.25","total_whole":"419,411","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2967300,"accession":"0001209191-20-042085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042085","line_url":"/filing/0001209191-20-042085#line-2","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1995.0,"shares_display":"1,995","price_per_share":31.63,"price_display":"31.63","price_state":"stated","total_value":63101.85,"total_display":"63,101.85","total_whole":"63,102","shares_owned_after":567290.0,"shares_owned_after_display":"567,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":3313033,"accession":"0001209191-20-033310","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-033310","line_url":"/filing/0001209191-20-033310#line-7","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":42.7,"price_display":"42.70","price_state":"stated","total_value":5337500.0,"total_display":"5,337,500.00","total_whole":"5,337,500","shares_owned_after":554285.0,"shares_owned_after_display":"554,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-06-01","scope":"insider"},{"id":8514553,"accession":"0001209191-19-031452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-031452","line_url":"/filing/0001209191-19-031452#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001775490","owner_name":"Shendelman Shoshana","owner_display_name":"Shendelman Shoshana","owner_url":"/insider/0001775490","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1250000.0,"total_display":"1,250,000.00","total_whole":"1,250,000","shares_owned_after":3605662.0,"shares_owned_after_display":"3,605,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001697532","name":"Applied Therapeutics, Inc.","url":"/issuer/0001697532","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":14,"first_seen":"2019-05-20","last_seen":"2024-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001775490","retrieved_at":"2026-08-22T05:02:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}